Form 4: 89bio CEO Rohan Palekar Reports Stock Transaction
SEC Form 4 Filing
Rohan Palekar, CEO of 89bio, Inc., reports the disposition of 4,601 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On August 17, 2024, Rohan Palekar, the CEO of 89bio, Inc. disposed of 4,601 shares of common stock.
- The transaction was executed to cover the estimated tax withholding obligation associated with the vesting of restricted stock units.
- The shares were disposed of at a price of $8.04 per share.
- Following the transaction, Palekar beneficially owns 456,236 shares of 89bio, Inc.
- This total includes 1,666 shares acquired through the company's 2019 Employee Stock Purchase Plan on June 28, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine stock transaction for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's stock activity related to tax obligations from vested stock units, which is a common occurrence.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| June 28, 2024 | Reporting person acquired 1,666 shares through the Issuer's 2019 Employee Stock Purchase Plan. |
| August 17, 2024 | CEO Rohan Palekar disposed of 4,601 shares of common stock to cover tax obligations. |
| August 19, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.